CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo

CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Healthcare
$0.27-3.30%ClosedMarket Cap: $5.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.00

P/S

148.17

EV/EBITDA

-1.04

DCF Value

$0.01

FCF Yield

-124.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

-1.3%

Operating Margin

-9154.6%

Net Margin

-9366.8%

ROE

-1569.1%

ROA

-55.0%

ROIC

-82.5%

Financials

View All
PeriodRevenueNet IncomeEPS
FY null$49.9K$-4.7M$
FY null$48.3K$-1.6M$
FY null$100.8K$-1.1M$
FY null$56.6K$-1.1M$

Trading Activity

Insider Trades

View All
TEO Peng Kwangdirector, 10 percent owner:
SellTue Apr 21
RAINA Natasha Kaurdirector:
SellTue Apr 21
QUEK David Yong Qidirector, 10 percent owner, officer: Chief Executive Officer
SellTue Apr 21
LEE Jimmy Peng Siewdirector, 10 percent owner:
SellTue Apr 21
KOH Pee Keatdirector:
SellTue Apr 21

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

SG

Exchange

Beta

1.93

Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.

Peers